Sinovac 重症化回避率は87.5%

各ワクチンの採用国数 https://t.co/X6qJSytGDn　AZは価格だけでなく保管が容易なため人気。変異株の感染を防げないとされるSinovacだが重症化回避率は87.5%。ワクチン接種の進んだ欧州内では接種率と感染率の相関が弱い状態となっており，ワクチンに期待されるのは感染防止ではなく重症化防止の局面に pic.twitter.com/seYO2OgRjy

— Spica (@Kelangdbn) July 15, 2021

Sinovac’s COVID-19 Vaccine is Able to Prevent over 80% of Deaths, according to Turkish and Chilean Studies

Medicines & Vaccines 09/07/2021 • Kerry Cullinan

CoronaVac, the Chinese vaccine developed by Sinovac, offers 83.5% protection against symptomatic COVID-19, according to interim data from a Phase 3 trial in Turkey published in the Lancet on Friday. 

Meanwhile, a large study of the efficacy of the vaccine on 10.2 million Chileans found that it was 65.9% effective in preventing infection, 87,5% effective in preventing hospitalisation and 86% effective in preventing death after two doses, according to a report published in the New England Journal of Medicine on Thursday.

 87.5%　入院予防できれば、御の字じゃないですかね？